HHS Inspector General Finds FDA Spends User Fees Appropriately
By Zachary Brennan -
Published 05 October 2017
The US Department of Health and Human Services’ (HHS) Office of Inspector General on Thursday released a report finding that the Food and Drug Administration (FDA) generally spent prescription drug user fees appropriately.
Categories: News, US, FDA, Compliance, Drugs, Government affairs
Tags: HHS OIG, user fee expenses, prescription drug user fees